Peptidicagonists of the glucagon-like peptide-1 receptor (GLP-1R)have gained a prominent role in the therapy of type-2 diabetes andare being considered for reducing food intake in obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.